Jeanne Farrell,
Business Development Director,
Ichan School of Medicine
As Business Development Director at Mount Sinai, Jeanne leads the technology development and commercialization efforts of the cancer portfolio. These assets vary widely and include diagnostics, prognostics, and therapeutics, often at very early stages. She also scouts internally and guides researchers with promising ideas and translational interests on how to drive these ideas towards discovery and positioning for partnering. She has successfully identified, and secured internal gap funding for, advancement of early projects that resulted in partnerships with commercial entities. Jeanne’s responsibilities also include education about Mount Sinai’s “innovation agenda” and external outreach and alliance management. Jeanne is a key member of the Mount Sinai Innovation Partners team and has closed a number of oncology-related licensing, sponsored research, and development agreements around pre-clinical technologies. She also holds responsibilities at Mount Sinai on the Conflict of Interest Committee and the IP Policy Committee. Prior to her current position, she was a member of the licensing group at Memorial Sloan Kettering Cancer Center. Jeanne holds a doctoral degree in Pharmacology from Weill Cornell Graduate School of Medical Sciences. She is also a registered patent agent with the USPTO.
|
|
The Evolution of Academic Technology TransferThursday, 25 September 2014 at 09:00 Add to Calendar ▼2014-09-25 13:00:002014-09-25 14:00:00Europe/LondonExpert Panel Discussion on "Public and Private Partnerships"Academic Discovery Workshop in Baltimore, MD, USABaltimore, MD, USASELECTBIOenquiries@selectbiosciences.com This presentation addresses the changes (and need for change) occurring in the approach by academic institutions to address drug discovery and development, as well as the new partnership opportunities with Pharma, Biotech, and academic spin-out companies.
|